158 related articles for article (PubMed ID: 16878150)
41. The receptor protein tyrosine phosphatase (RPTP)beta/zeta is expressed in different subtypes of human breast cancer.
Perez-Pinera P; Garcia-Suarez O; Menendez-Rodriguez P; Mortimer J; Chang Y; Astudillo A; Deuel TF
Biochem Biophys Res Commun; 2007 Oct; 362(1):5-10. PubMed ID: 17706593
[TBL] [Abstract][Full Text] [Related]
42. Phosphoproteomic analysis of anaplastic lymphoma kinase (ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells.
Sattu K; Hochgräfe F; Wu J; Umapathy G; Schönherr C; Ruuth K; Chand D; Witek B; Fuchs J; Li PK; Hugosson F; Daly RJ; Palmer RH; Hallberg B
FEBS J; 2013 Nov; 280(21):5269-82. PubMed ID: 23889739
[TBL] [Abstract][Full Text] [Related]
43. Cooperative transformation of 32D cells by the combined expression of IRS-1 and V-Ha-Ras.
Cristofanelli B; Valentinis B; Soddu S; Rizzo MG; Marchetti A; Bossi G; Morena AR; Dews M; Baserga R; Sacchi A
Oncogene; 2000 Jul; 19(29):3245-55. PubMed ID: 10918581
[TBL] [Abstract][Full Text] [Related]
44. Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.
Webb TR; Slavish J; George RE; Look AT; Xue L; Jiang Q; Cui X; Rentrop WB; Morris SW
Expert Rev Anticancer Ther; 2009 Mar; 9(3):331-56. PubMed ID: 19275511
[TBL] [Abstract][Full Text] [Related]
45. Activation and inhibition of anaplastic lymphoma kinase receptor tyrosine kinase by monoclonal antibodies and absence of agonist activity of pleiotrophin.
Moog-Lutz C; Degoutin J; Gouzi JY; Frobert Y; Brunet-de Carvalho N; Bureau J; Créminon C; Vigny M
J Biol Chem; 2005 Jul; 280(28):26039-48. PubMed ID: 15886198
[TBL] [Abstract][Full Text] [Related]
46. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth.
Keegan AD; Nelms K; White M; Wang LM; Pierce JH; Paul WE
Cell; 1994 Mar; 76(5):811-20. PubMed ID: 8124718
[TBL] [Abstract][Full Text] [Related]
47. Interleukin 4 signals through two related pathways.
Pernis A; Witthuhn B; Keegan AD; Nelms K; Garfein E; Ihle JN; Paul WE; Pierce JH; Rothman P
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7971-5. PubMed ID: 7544011
[TBL] [Abstract][Full Text] [Related]
48. Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth.
Powers C; Aigner A; Stoica GE; McDonnell K; Wellstein A
J Biol Chem; 2002 Apr; 277(16):14153-8. PubMed ID: 11809760
[TBL] [Abstract][Full Text] [Related]
49. ALK+ALCLs induce cutaneous, HMGB-1-dependent IL-8/CXCL8 production by keratinocytes through NF-κB activation.
Dejean E; Foisseau M; Lagarrigue F; Lamant L; Prade N; Marfak A; Delsol G; Giuriato S; Gaits-Iacovoni F; Meggetto F
Blood; 2012 May; 119(20):4698-707. PubMed ID: 22394598
[TBL] [Abstract][Full Text] [Related]
50. Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma.
Regairaz M; Munier F; Sartelet H; Castaing M; Marty V; Renauleaud C; Doux C; Delbé J; Courty J; Fabre M; Ohta S; Vielh P; Michiels S; Valteau-Couanet D; Vassal G
Am J Pathol; 2016 Feb; 186(2):435-45. PubMed ID: 26687816
[TBL] [Abstract][Full Text] [Related]
51. The Drosophila midkine/pleiotrophin homologues Miple1 and Miple2 affect adult lifespan but are dispensable for alk signaling during embryonic gut formation.
Hugosson F; Sjögren C; Birve A; Hedlund L; Eriksson T; Palmer RH
PLoS One; 2014; 9(11):e112250. PubMed ID: 25380037
[TBL] [Abstract][Full Text] [Related]
52. Midkine induces tumor cell proliferation and binds to a high affinity signaling receptor associated with JAK tyrosine kinases.
Ratovitski EA; Kotzbauer PT; Milbrandt J; Lowenstein CJ; Burrow CR
J Biol Chem; 1998 Feb; 273(6):3654-60. PubMed ID: 9452495
[TBL] [Abstract][Full Text] [Related]
53. Anaplastic lymphoma kinase in human cancer.
Barreca A; Lasorsa E; Riera L; Machiorlatti R; Piva R; Ponzoni M; Kwee I; Bertoni F; Piccaluga PP; Pileri SA; Inghirami G;
J Mol Endocrinol; 2011 Aug; 47(1):R11-23. PubMed ID: 21502284
[TBL] [Abstract][Full Text] [Related]
54. Nuclear translocation of insulin receptor substrate-1 by the simian virus 40 T antigen and the activated type 1 insulin-like growth factor receptor.
Prisco M; Santini F; Baffa R; Liu M; Drakas R; Wu A; Baserga R
J Biol Chem; 2002 Aug; 277(35):32078-85. PubMed ID: 12063262
[TBL] [Abstract][Full Text] [Related]
55. Functional role of ALK-related signal cascades on modulation of epithelial-mesenchymal transition and apoptosis in uterine carcinosarcoma.
Inoue H; Hashimura M; Akiya M; Chiba R; Saegusa M
Mol Cancer; 2017 Feb; 16(1):37. PubMed ID: 28193280
[TBL] [Abstract][Full Text] [Related]
56. Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion.
Englund C; Lorén CE; Grabbe C; Varshney GK; Deleuil F; Hallberg B; Palmer RH
Nature; 2003 Oct; 425(6957):512-6. PubMed ID: 14523447
[TBL] [Abstract][Full Text] [Related]
57. Ethanol activates midkine and anaplastic lymphoma kinase signaling in neuroblastoma cells and in the brain.
He D; Chen H; Muramatsu H; Lasek AW
J Neurochem; 2015 Nov; 135(3):508-21. PubMed ID: 26206265
[TBL] [Abstract][Full Text] [Related]
58. FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase.
Guan J; Umapathy G; Yamazaki Y; Wolfstetter G; Mendoza P; Pfeifer K; Mohammed A; Hugosson F; Zhang H; Hsu AW; Halenbeck R; Hallberg B; Palmer RH
Elife; 2015 Sep; 4():e09811. PubMed ID: 26418745
[TBL] [Abstract][Full Text] [Related]
59. Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions.
Reshetnyak AV; Murray PB; Shi X; Mo ES; Mohanty J; Tome F; Bai H; Gunel M; Lax I; Schlessinger J
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15862-7. PubMed ID: 26630010
[TBL] [Abstract][Full Text] [Related]
60. IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells.
Wang LM; Myers MG; Sun XJ; Aaronson SA; White M; Pierce JH
Science; 1993 Sep; 261(5128):1591-4. PubMed ID: 8372354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
